Literature DB >> 10212575

Fluorescence spectral properties of the anticancer drug topotecan by steady-state and frequency domain fluorometry with one-photon and multi-photon excitation.

I Gryczynski1, Z Gryczynski, J R Lakowicz, D Yang, T G Burke.   

Abstract

Topotecan is an antitumor agent with activity against a variety of cancers. We examined the steady-state and time-resolved fluorescence spectral properties of topotecan with one- and two-photon excitation. Topotecan was found to display a high two-photon cross section near 20 GM for wavelengths within the fundamental output of a Ti:sapphire laser, 800-880 nm. In frozen solution the anisotropies of topotecan are near the theoretical maxima for one-photon and two-photon excitation with colinear electronic transitions. The intensity and anisotropy decays of topotecan fluorescence were found to be homogeneous (single exponentials) in phosphate-buffered saline and propylene glycol. The steady-state and time-resolved data indicate that topotecan binds to a double-helical DNA oligomer d(AT)10 resulting in increased anisotropies and multiexponential intensity and anisotropy decays. Subnanosecond components in the anisotropy decay of the DNA-topotecan complex suggest loose binding of the drug to DNA. Loose binding of topotecan to DNA is also revealed by accessibility of topotecan to collisional quenching by iodide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212575

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  2 in total

1.  A quantitative characterization of interaction between prion protein with nucleic acids.

Authors:  Alakesh Bera; Sajal Biring
Journal:  Biochem Biophys Rep       Date:  2018-05-02

2.  Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074.

Authors:  Bernhard Englinger; Sebastian Kallus; Julia Senkiv; Anna Laemmerer; Patrick Moser; Lisa Gabler; Diana Groza; Christian R Kowol; Petra Heffeter; Michael Grusch; Walter Berger
Journal:  Cells       Date:  2018-12-08       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.